Literature DB >> 8408599

Prognostic value of background patterns in the neonatal EEG.

G L Holmes1, C T Lombroso.   

Abstract

The prognostic value of background activity in the neonatal EEG has been well established. Whereas in older children the neonatal EEG is useful in the diagnosis of seizures, in neonates the test also provides a particularly valuable assessment of cerebral functioning following a variety of insults. In this review, the prognostic significance of abnormalities of amplitude, continuity, frequency, symmetry, synchrony, sleep state, and maturation are discussed. Certain abnormalities, such as cerebral electrical inactivity or burst suppression, are highly predictive of outcome, whereas other abnormalities of background activity are associated with more variable outcomes. Since the ill neonate may have more than one abnormality, predicting outcome based on a single EEG feature is discouraged. As in older children, drugs may affect EEG background rhythms. Although abnormalities on the neonatal EEG are not specific for diagnosis, certain EEG patterns may be highly suggestive for the diagnosis of pyridoxine dependency and neonatal herpes encephalitis. In both term and preterm infants, the prognostic value of the neonatal EEG is increased by performing serial studies.

Entities:  

Mesh:

Year:  1993        PMID: 8408599     DOI: 10.1097/00004691-199307000-00008

Source DB:  PubMed          Journal:  J Clin Neurophysiol        ISSN: 0736-0258            Impact factor:   2.177


  30 in total

Review 1.  Continuous electroencephalography monitoring in neonates.

Authors:  Renée A Shellhaas
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

2.  Amplitude-integrated electroencephalography in full-term newborns without severe hypoxic-ischemic encephalopathy: case series.

Authors:  Damjan Osredkar; Metka Derganc; Darja Paro-Panjan; David Neubauer
Journal:  Croat Med J       Date:  2006-04       Impact factor: 1.351

Review 3.  Review of sleep-EEG in preterm and term neonates.

Authors:  Anneleen Dereymaeker; Kirubin Pillay; Jan Vervisch; Maarten De Vos; Sabine Van Huffel; Katrien Jansen; Gunnar Naulaers
Journal:  Early Hum Dev       Date:  2017-07-12       Impact factor: 2.079

4.  Seizures and magnetic resonance imaging-detected brain injury in newborns cooled for hypoxic-ischemic encephalopathy.

Authors:  Hannah C Glass; Kendall B Nash; Sonia L Bonifacio; A James Barkovich; Donna M Ferriero; Joseph E Sullivan; Maria Roberta Cilio
Journal:  J Pediatr       Date:  2011-08-11       Impact factor: 4.406

Review 5.  EEG monitoring during therapeutic hypothermia in neonates, children, and adults.

Authors:  Nicholas S Abend; Ram Mani; Tammy N Tschuda; Tae Chang; Alexis A Topjian; Maureen Donnelly; Denise LaFalce; Margaret C Krauss; Sarah E Schmitt; Joshua M Levine
Journal:  Am J Electroneurodiagnostic Technol       Date:  2011-09

6.  Quick and accurate quantification of the premature brain.

Authors:  Catherine J Chu
Journal:  Clin Neurophysiol       Date:  2016-05-04       Impact factor: 3.708

7.  Ischemic injury suppresses hypoxia-induced electrographic seizures and the background EEG in a rat model of perinatal hypoxic-ischemic encephalopathy.

Authors:  A Zayachkivsky; M J Lehmkuhle; J J Ekstrand; F E Dudek
Journal:  J Neurophysiol       Date:  2015-09-09       Impact factor: 2.714

8.  Thalamus Controls Development and Expression of Arousal States in Visual Cortex.

Authors:  Yasunobu Murata; Matthew T Colonnese
Journal:  J Neurosci       Date:  2018-08-27       Impact factor: 6.167

9.  Brain perfusion in encephalopathic newborns after therapeutic hypothermia.

Authors:  A N Massaro; M Bouyssi-Kobar; T Chang; L G Vezina; A J du Plessis; C Limperopoulos
Journal:  AJNR Am J Neuroradiol       Date:  2013-03-14       Impact factor: 3.825

10.  Technical standards for recording and interpretation of neonatal electroencephalogram in clinical practice.

Authors:  Perumpillichira J Cherian; Renate M Swarte; Gerhard H Visser
Journal:  Ann Indian Acad Neurol       Date:  2009-01       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.